Vanda Pharmaceuticals Inc. (VNDA) › Cost of RevenueVanda Pharmaceuticals Inc. (VNDA) — Cost of RevenueAnnual figures by period end, from SEC filings.2009-12-31: $1.92M2010-12-31: $2.89M2012-12-31: $129.0K2014-12-31: $1.58M2015-12-31: $23.46M$23.46M2009-12-31Cost of Revenue (USD)2015-12-31Period endedCost of RevenueChange YoYSource filing2015-12-31$23.46M+1382.1%2016-02-12From 2015-01-012014-12-31$1.58M—2016-02-12From 2014-01-012012-12-31$129.0K—2015-03-13From 2012-01-012010-12-31$2.89M+51.0%2013-02-26From 2010-01-012009-12-31$1.92M—2012-03-09From 2009-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)